These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34991633)

  • 21. Identification and functional analysis of sequence variants in the long control region and the E2 open reading frame of bovine papillomavirus type 1 isolated from equine sarcoids.
    Nasir L; Gault E; Morgan IM; Chambers G; Ellsmore V; Campo MS
    Virology; 2007 Aug; 364(2):355-61. PubMed ID: 17412385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bovine papillomavirus DNA in neoplastic and nonneoplastic tissues obtained from horses with and without sarcoids in the western United States.
    Carr EA; Théon AP; Madewell BR; Griffey SM; Hitchcock ME
    Am J Vet Res; 2001 May; 62(5):741-4. PubMed ID: 11341396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Establishment and characterization of equine fibroblast cell lines transformed in vivo and in vitro by BPV-1: model systems for equine sarcoids.
    Yuan ZQ; Gault EA; Gobeil P; Nixon C; Campo MS; Nasir L
    Virology; 2008 Apr; 373(2):352-61. PubMed ID: 18191170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic evaluation of bovine papillomavirus types detected in equine sarcoids in Poland.
    Szczerba-Turek A; Siemionek J; Ras A; Bancerz-Kisiel A; Platt-Samoraj A; Lipczynska-Ilczuk K; Szweda W
    Pol J Vet Sci; 2019 Mar; 22(1):25-29. PubMed ID: 30997762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Localization of Bovine papillomavirus in equine sarcoids and inflammatory skin conditions of horses using laser microdissection and two forms of DNA amplification.
    Wobeser BK; Hill JE; Jackson ML; Kidney BA; Mayer MN; Townsend HG; Allen AL
    J Vet Diagn Invest; 2012 Jan; 24(1):32-41. PubMed ID: 22362933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bovine papillomavirus infection in equine sarcoids and in bovine bladder cancers.
    Yuan Z; Gallagher A; Gault EA; Campo MS; Nasir L
    Vet J; 2007 Nov; 174(3):599-604. PubMed ID: 17150387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymerase chain reaction analysis of the surgical margins of equine sarcoids for bovine papilloma virus DNA.
    Martens A; De Moor A; Demeulemeester J; Peelman L
    Vet Surg; 2001; 30(5):460-7. PubMed ID: 11555822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bovine papillomaviral gene expression in equine sarcoid tumours.
    Nasir L; Reid SW
    Virus Res; 1999 Jun; 61(2):171-5. PubMed ID: 10475087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity analysis of BPV-1 positive equine sarcoid-derived cultured fibroblasts.
    Gysens L; Depuydt E; Patruno M; Haspeslagh M; Spaas JH; Martens A
    Vet Immunol Immunopathol; 2023 Feb; 256():110547. PubMed ID: 36621059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular and epigenetic analysis of the fragile histidine triad tumour suppressor gene in equine sarcoids.
    Strazzullo M; Corteggio A; Altamura G; Francioso R; Roperto F; D'Esposito M; Borzacchiello G
    BMC Vet Res; 2012 Mar; 8():30. PubMed ID: 22424615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Morphologic and molecular biologic studies of the etiology of equine sarcoid].
    Teifke JP
    Tierarztl Prax; 1994 Aug; 22(4):368-76. PubMed ID: 7940516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The possible role of Stomoxys calcitrans in equine sarcoid transmission.
    Haspeslagh M; Vlaminck L; Martens A
    Vet J; 2018 Jan; 231():8-12. PubMed ID: 29429489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. E5 nucleotide polymorphisms suggest quasispecies occurrence in BPV-1 sub-clinically infected horses.
    Savini F; Gallina L; Prosperi A; Battilani M; Bettini G; Scagliarini A
    Res Vet Sci; 2015 Oct; 102():80-2. PubMed ID: 26412524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of the long control region of bovine papillomavirus type 1 associated with sarcoids in equine hosts indicates multiple cross-species transmission events and phylogeographical structure.
    Trewby H; Ayele G; Borzacchiello G; Brandt S; Campo MS; Del Fava C; Marais J; Leonardi L; Vanselow B; Biek R; Nasir L
    J Gen Virol; 2014 Dec; 95(Pt 12):2748-2756. PubMed ID: 25185436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bovine Papillomavirus DNA and S100 Profiles in Sarcoids and Other Cutaneous Spindle Cell Tumors in Horses.
    Epperson ED; Castleman WL
    Vet Pathol; 2017 Jan; 54(1):44-52. PubMed ID: 27312364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunotherapy of equine sarcoid: dose-escalation trial for the use of chimeric papillomavirus-like particles.
    Mattil-Fritz S; Scharner D; Piuko K; Thönes N; Gissmann L; Müller H; Müller M
    J Gen Virol; 2008 Jan; 89(Pt 1):138-147. PubMed ID: 18089737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p38 mitogen-activated protein kinase is crucial for bovine papillomavirus type-1 transformation of equine fibroblasts.
    Yuan Z; Gault EA; Campo MS; Nasir L
    J Gen Virol; 2011 Aug; 92(Pt 8):1778-1786. PubMed ID: 21471309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of BPV-like DNA in equine sarcoids.
    Angelos JA; Marti E; Lazary S; Carmichael LE
    Arch Virol; 1991; 119(1-2):95-109. PubMed ID: 1650553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential expression of microRNAs in bovine papillomavirus type 1 transformed equine cells.
    Terron-Canedo N; Weir W; Nicolson L; Britton C; Nasir L
    Vet Comp Oncol; 2017 Sep; 15(3):764-774. PubMed ID: 27039895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peripheral blood mononuclear cells represent a reservoir of bovine papillomavirus DNA in sarcoid-affected equines.
    Brandt S; Haralambus R; Schoster A; Kirnbauer R; Stanek C
    J Gen Virol; 2008 Jun; 89(Pt 6):1390-1395. PubMed ID: 18474554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.